June 20, 2024 C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data C-Path announced the targeted integration of additional Friedreich’s ataxia...
June 24, 2024-June 25, 2024 C-Path’s Stephenson to Serve as Co-panelist for FNIH Digital Technologies Summit C-Path's Executive Director, Critical Path for Parkinson's (CPP) Consortium, Diane Stephenson will join as a...
June 12, 2024 Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 months Digital measures may provide objective, sensitive, real-world measures of disease progression in Parkinson’s disease (PD).
June 12, 2024 C-Path’s AI Collaborations Accelerate Drug Development, Improve Lives Critical Path Institute (C-Path) today announced the publication of a new peer-reviewed paper in the journal Clinical and...
June 12, 2024 C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing Smartwatches to Monitor Disease Progression Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology...
June 10, 2024 Advocate Sarah Dolan Brings a Patient Voice to FDA Committee Reviewing New Alzheimer’s Drug Donanemab On Monday, June 10, the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory...
June 20, 2024 Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease C-Path's Rare and Orphan Disease Programs is excited to have Dr. Anthony Bleyer present it's June webinar...
June 5, 2024 eCOA Masterclass #1: The Road to Best Practice Consensus: Electronic Migration and Implementation of PRO Measures Join the co-authors of the published article in Value in Health for a deep dive into existing and current best practices for the..
May 30, 2024 C-Path Supports Gleason, ALS Community at IgNight ALS The C-Path team was incredibly humbled to be a part of IgNight ALS recently in Washington, D.C., honoring Steve Gleason and celebr
May 28, 2024 Accelerating healthcare innovation: the role of Artificial intelligence and digital health technologies in critical path institute’s public-private partnerships Artificial Intelligence (AI) and Digital Health Technologies (DHTs) are radically transforming drug development. The FDA and EMA..